NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US
The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.
- The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.
- A joint abstract by Dr. Low and Dr. Hawking featuring Dr. Hawking’s brain patterns analyzed by NeuroVigil’s technology was released as early as 2012.
- The technology was also successfully demonstrated on ALS sufferer Augie Nieto in 2013 who spelled “COMMUNICATE” with his mind.
- In the past two years, NeuroVigil has recruited talent from Amgen, Roche, Novartis and MIT in preparation for the launch.